Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Supportive Care in Cancer
Erschienen in: Supportive Care in Cancer 11/2019

21.03.2019 | Original Article

Depression as mediator and or moderator on the relationship between hopelessness and patients’ desire for hastened death

verfasst von: Efi Parpa, Eleni Tsilika, Antonis Galanos, Maria Nikoloudi, Kyriaki Mystakidou

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Previous findings have shown that depression in advanced stages of cancer is associated with hopelessness and frequently with wishes for hastened death. The current study tries to investigate the relationship between hopelessness and desire for hastened death and if depression may be a moderator and/or mediator role in patients with advanced cancer.

Method

The participants were 102 patients with advanced cancer which they completed the Beck Hopelessness Scale (BHS), the Greek Schedule of Attitudes towards Hastened Death (G-SAHD), and the Greek Beck Depression Inventory (BDI).

Results

Depression was highly correlated with hopelessness and desire for hastened death. Mediation analyses revealed that hopelessness influenced desire for hastened death as well as indirectly by its effect on depression. Similarly, depression was found as moderator in the relationship between hopelessness with desire for hastened death.

Conclusions

Hopelessness and desire for hastened death in patients with advanced cancer should be diagnosed and treated by taking into consideration the optimum care of depression as a priority in palliative care.
Literatur
1.
Payne DK, Massie M (2002) In: Berger A, Portenoy RK, Weissman DE (eds) Principles and practice of palliative care and supportive oncology, 2nd edn. Lippincott Williams & Wilkins Publishers, Philadelphia
2.
Hosang GM, Shiles C, Tansey KE, McGuffin P, Uher R (2014) Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis. BMC Med 12:7PubMedPubMedCentral
3.
Walker J, Hansen CH, Martin P, Symeonides S, Gourley C, Wall L, Weller D, Murray G, Sharpe M, SMaRT (Symptom Management Research Trials) Oncology-3 Team (2014) Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer. Lancet Oncol 15:1168–1176PubMed
4.
Walker J, Hansen CH, Martin P, Symeonides S, Ramessur R, Murray G, Sharpe M (2014) Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. Lancet Psych 1(5):343–350
5.
Krebber AMH, Buffart LM, Kleijn G, Riepma IC, de Bree R, Leemans CR, Becker A, Brug J, van Straten A, Cuijpers P, Verdonck-de Leeuw IM (2014) Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psycho-Oncol 23:121–130
6.
Massie MJ (2004) Prevalence of depression in patients with cancer. J Natl Cancer Inst Mongr 32:57–71
7.
Vodermaier A, Linden W, Siu C (2009) Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 101:1464–1488PubMedPubMedCentral
8.
Breitbart W, Rosenfeld B, Pessin H, Kaim M, Funesti-Esch J, Galietta M, Nelson CJ, Brescia R (2000) Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA 284:2907–2911PubMed
9.
Laird BJ, Boyd AC, Colvin LA, Fallon MT (2009) Are cancer pain and depression interdependent? A systematic review. Psycho-Oncol 18:459–464
10.
11.
Block SD (2000) Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians - American Society of Internal Medicine. Ann Intern Med 132:209–218PubMed
12.
Lo C, Zimmermann C, Rydall (2010) Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. J Clin Oncol 28:3084–3089PubMed
13.
Walker J, Waters RA, Murray G, Swanson H, Hibberd CJ, Rush RW, Storey DJ, Strong VA, Fallon MT, Wall LR, Sharpe M (2008) Better off dead: suicidal thoughts in cancer patients. J Clin Oncol 26:4725–4730PubMed
14.
15.
Rustoen T, Wiklund I (2000) Hope in newly diagnosed patients with cancer. Cancer Nurs 23:214–217PubMed
16.
McClement SE, Chochinov HM (2008) Hope in advanced cancer patients. Eur J Cancer 44:1169–1174PubMed
17.
Akechi T, Kugaya A, Okamura H, Nishiwaki Y, Yamawaki S, Uchitomi Y (1998) Predictive factors for psychological distress in ambulatory lung cancer patients. Support Care Cancer 6:281–286PubMed
18.
Pessin H, Rosenfeld B, Breitbart W (2002) Assessing psychological distress near the end of life. Am Behav Sci 46:357–372
19.
Avci IA, Okanli A, Karabulutlu E, Bilgili N (2009) Women’s marital adjustment and hopelessness levels after mastectomy. Eur J Oncol Nurs 13:299–303PubMed
20.
Chochinov HM, Wilson KG, Enns M, Mowchun N, Lander S, Levitt M, Clinch JJ (1995) Desire for death in the terminally ill. Am J Psychiatry 152:1185–1191PubMed
21.
Brown JH, Henteleff P, Barakat S, Rowe CJ (1986) Is it normal for terminally ill patients to desire death? Am J Psychiatry 143:208–211PubMed
22.
Breitbart W, Rosenfeld B, Passik S (1996) Interest in physician assisted suicide among ambulatory HIV-infected patients. Am J Psychiatry 153:238–242PubMed
23.
Chochinov HM, Wilson KG, Enns M, Lander S (1998) Depression, hopelessness, and suicidal ideation in the terminally ill. Psychosomatics 39:366–370PubMed
24.
Kelly B, Burnett P, Pelusi D (2003) Factors associated with the wish to hasten death: a study of patients with terminal illness. Psychol Med 33:75–81PubMed
25.
Morita T, Kawa M, Honke Y (2004) Existential concerns of terminally ill cancer patients receiving specialized palliative care in Japan. Support Care Cancer 12:137–140PubMed
26.
McClain CS, Rosenfeld B, Breitbart W (2003) Effect of spiritual well-being on end-of-life despair in terminally ill cancer patients. Lancet 361:1603–1607PubMed
27.
Chochinov HM, Hack T, Hassard T (2005) Understanding the will to live in patients nearing death. Psychosomatics 46:7–10PubMed
28.
29.
Akechi T, Okamura H, Yamawaki S, Uchitomi Y (2001) Why do some cancer patients with depression desire an early death and others do not? Psychosomatics 42:141–145PubMed
30.
Rosenfeld B, Breitbart W, Galietta M, Kaim M, Funesti-Esch J, Pessin H, Nelson CJ, Brescia R (2000) The schedule of attitudes toward hastened death: measuring desire for death in terminally ill cancer patients. Cancer 88:2868–2875PubMed
31.
Mystakidou K, Rosenfeld B, Parpa E, Tsilika E, Katsouda E, Galanos A, Vlahos L (2004) The schedule of attitudes toward hastened death: validation analysis in teminally ill cancer patients. Palliat Support Care 2:395–402PubMed
32.
Mystakidou K, Tsilika E, Parpa E et al (2007) Beck depression inventory: exploring its psychometric properties in a palliative care population of advanced cancer patients. Eur J Cancer Care 16:244–250
33.
Beck AT, Ward CH, Mendeson M, Mock J, Arbough J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:53–63
34.
Beck AT, Weissman A, Lester D, Trexler L (1974) The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 42:861–865PubMed
35.
Preacher KJ, Hayes AF (2004) SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Meth Instrum Comput 36:717–731
36.
37.
Pasquini M, Biondi M (2007) Depression in cancer patients: a critical review. Clin Pract Epidemiol Ment Health 3:2PubMedPubMedCentral
38.
Caruso RM, Nanni G, Riba M et al (2017) Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review. Acta Oncol 56:146–155PubMed
39.
Rosenfeld B, Breitbart W, Stein K (1999) Measuring desire for death among patients with HIV/AIDS: the schedule of attitudes toward hastened death. Am J Psychiatry 156:94–99PubMed
40.
41.
Smith EM, Gomm SA, Dickens CM (2003) Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer. Palliat Med 17:509–513PubMed
42.
Jones JM, Huggins MA, Rydall AC, Rodin GM (2003) Symptomatic distress, hopelessness, and the desire for hastened death in hospitalized cancer patients. J Psychosom Res 55:411–418PubMed
43.
Mystakidou K, Tsilika E, Parpa E, Athanasouli P, Galanos A, Anna P, Vlahos L (2009) Illness-related hopelessness in advanced cancer: influence of anxiety, depression, and preparatory grief. Arch Psychiatr Nurs 23:138–147PubMed
44.
Robinson S, Kissane W, Brooker J et al (2017) The relationship between poor quality of life and desire to hasten death: a multiple mediation model examining the contributions of depression, demoralization, loss of control, and low self-worth. J Pain Symptom Manag 53:243–249
45.
Wilson KG, Dalgleish TL, Chochinov HM, Chary S, Gagnon PR, Macmillan K, de Luca M, O'Shea F, Kuhl D, Fainsinger RL (2016) Mental disorders and the desire for death in patients receiving palliative care for cancer. BMJ Support Palliat Care 6:170–177PubMed
46.
Sachs E, Kolva E, Pessin H, Rosenfeld B, Breitbart W (2012) On sinking and swimming: the dialectic of hope, hopelessness, and acceptance in terminal cancer. Am J Hosp Palliat Med 30:121–127
47.
Wilson KG, Lander M, Chochinov HM (2009) Diagnosis and management of depression. In: Chochinov H, Breitbart W (eds) Handbook of psychiatry in palliative medicine, 2dn. Oxford University Press, New York, pp 39–68
Metadaten
Titel
Depression as mediator and or moderator on the relationship between hopelessness and patients’ desire for hastened death
verfasst von
Efi Parpa
Eleni Tsilika
Antonis Galanos
Maria Nikoloudi
Kyriaki Mystakidou
Publikationsdatum
21.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 11/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04715-2

Weitere Artikel der Ausgabe 11/2019

Supportive Care in Cancer 11/2019 Zur Ausgabe

Original Article

Decision-making in childhood cancer: parents’ and adolescents’ views and perception

Original Article

Feasibility of a mindful yoga program for women with metastatic breast cancer: results of a randomized pilot study

Original Article

Predictors of the therapeutic effect of corticosteroids on radiation-induced optic neuropathy following nasopharyngeal carcinoma

Original Article

Evaluation of antiemetic practices for prevention of chemotherapy-induced nausea and vomiting (CINV): results of a European oncology nurse survey

Original Article

Understanding the roles of patient symptoms and subjective appraisals in well-being among breast cancer patients

Original Article

Body changes after cancer: female cancer patients’ perceived social support and their perspective on care

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise